In a decisive move aimed at curbing the rising threat of synthetic opioids, the UK government has announced the strict classification of six new synthetic opioids under the Misuse of Drugs Act 1971. This measure seeks to mitigate drug-related deaths and impose tougher penalties on individuals involved in their production and distribution.
[block_2]
Following the recommendation of the Advisory Council on the Misuse of Drugs (ACMD), the government has agreed to classify six acyl piperazine opioids and derivatives, including 2-methyl-AP-237, as Class A drugs. This designation underscores the severity of the consequences for anyone caught supplying these substances, with potential penalties including life imprisonment, unlimited fines, or both.